Stocks
Funds
Screener
Sectors
Watchlists
PODD

PODD - Insulet Corp Stock Price, Fair Value and News

$219.84-16.23 (-6.88%)
Delayed

57/100

PODD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

57/100

PODD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PODD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PODD Price Action

Last 7 days

-7.2%

Last 30 days

-12.4%

Last 90 days

-25.6%

Trailing 12 Months

-10.1%

PODD RSI Chart

PODD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PODD Valuation

Market Cap

15.5B

Price/Earnings (Trailing)

62.63

Price/Sales (Trailing)

5.71

EV/EBITDA

36.5

Price/Free Cashflow

40.97

PODD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PODD Fundamentals

PODD Revenue

Revenue (TTM)

2.7B

Rev. Growth (Yr)

31.17%

Rev. Growth (Qtr)

10.97%

PODD Earnings

Earnings (TTM)

247.1M

Earnings Growth (Yr)

0.89%

Earnings Growth (Qtr)

15.98%

PODD Profitability

EBT Margin

12.54%

Return on Equity

16.31%

Return on Assets

7.75%

Free Cashflow Yield

2.44%

PODD Investor Care

Shares Dilution (1Y)

0.24%

Diluted EPS (TTM)

3.49

PODD Alerts

  • 2 major insider buys recently.
  • Big jump in Revenue (Y/Y)

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.2B2.4B2.5B2.7B
20241.8B1.9B2.0B2.1B
20231.4B1.5B1.6B1.7B
20221.1B1.2B1.2B1.3B
2021958.7M995.6M1.0B1.1B
2020776.6M825.8M867.7M904.4M
2019599.8M652.7M693.7M738.2M
2018485.7M500.1M529.4M563.8M
2017387.5M409.9M436.8M463.8M
2016297.0M323.7M347.2M367.0M
2015224.1M227.1M238.5M263.9M
2014245.1M242.6M241.5M231.3M
2013221.0M230.0M236.4M247.1M
2012171.8M190.6M200.7M211.4M
2011104.4M113.7M132.8M152.3M
PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
 CEO
 WEBSITEinsulet.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES2600

Insulet Corp Frequently Asked Questions


PODD is the stock ticker symbol of Insulet Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Insulet Corp is 15.48 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, PODD's PE ratio (Price to Earnings) is 62.63 and Price to Sales (PS) ratio is 5.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PODD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Insulet Corp has provided 0.217 (multiply by 100 for percentage) rate of return.